Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer, Study Shows
Researchers at Vanderbilt-Ingram Cancer Center report that RNA sequencing of blood samples can predict immunotherapy response in high-risk breast cancer patients.
Category: Breast
Breast
Latest
Breast
Latest
Blood Test May Help Guide Breast Cancer Treatment Decisions in Women 70 and Older
Researchers found that circulating tumor DNA testing could identify which older patients with estrogen receptor–positive breast cancer are less likely to respond to hormone therapy alone.
Breast
Latest
Test Validated to Predict Recurrence Risk and Radiation Therapy Benefit in Breast Cancer
A blinded validation in more than 400 women shows the test provides clearer guidance on recurrence risk and radiation therapy decisions.
PREDICT DNA and SCANDARE Study Results Unveiled
Personalis, Inc. unveiled promising new clinical data from the PREDICT DNA and SCANDARE studies at ASCO 2025.
Read More
MRD Detection Gets New Standard with Pathlight
SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.
Read More
Breast Cancer Index Test Data Reinforces Efficacy
Hologic and Biotheranostics unveiled new data showing that the Breast Cancer Index (BCI) test improves treatment decision-making.
Read More
Study IDs Two New Breast Cancer Genes in Black Women
A groundbreaking genetic study identified two novel breast cancer-linked genetic variants in Black South African women.
Read More
Ibex Breast Demonstrates High Accuracy, Efficiency in Study
A new peer-reviewed study confirms that Ibex Breast significantly enhances accuracy, speed, and efficiency of breast pathology evaluations.
Read More
Rethinking Breast Cancer Screening
A new editorial discusses findings from the COMET trial, suggesting that early-stage breast cancer may not require immediate surgery.
Read More
HER2-ultralow Metastatic Breast Cancer Companion Diagnostic Approved by FDA
Roche’s PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.
Read More
BioView Unveils Breakthrough Liquid Biopsy for HER2 Detection in Metastatic Breast Cancer
BioView’s liquid biopsy test offers a non-invasive method to detect HER2 status in metastatic breast cancer patients.
Read More
AI-Powered Blood Test Spots Earliest Sign of Breast Cancer
A new laser analysis and AI method capable of detecting stage 1a breast cancer with 98% accuracy offers an effective screening option.
Read More
New Genetic Breast Cancer Model Developed
A researcher’s new mouse model for studying breast cancer could enhance understanding of cancer metastasis and its spread to organs.
Read More
Alverno Labs Expands Practice of Ibex’s AI-Powered Cancer Diagnostics Platform
Alverno Laboratories has expanded its use of Ibex’s AI-powered cancer diagnostics platform to include breast cancer detection for patients.
Read More
Ibex Unveils Advancements in AI Breast Cancer Diagnostics Platform
Ibex has introduced advancements to its AI-powered platform, enhancing breast cancer diagnostics, improving algorithm accuracy, and more.
Read More
Many Breast Cancer Survivors Don’t Receive Genetic Testing, Despite Eligibility
Many breast cancer survivors who qualify for genetic testing are not receiving it, though those who do often discuss results with family.
Read More
New Blood Test Predicts Breast Cancer Recurrence Before Relapse
A new blood test can predict the recurrence of breast cancer in high-risk patients by detecting cancer DNA months or years before relapse.
Read More
PreciseDx Announces Poster Presentation for Breast Cancer Recurrence Test
PreciseDx will present findings on their AI-driven breast cancer recurrence prediction test at the 2024 ASCO Annual Meeting.
Read More